This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/513903-germany-rejects-astrazeneca-vaccine-over-65s/
The article has changed 5 times. There is an RSS feed of changes available.
| Version 2 | Version 3 |
|---|---|
| More ill tidings for EU as startling German announcement states AstraZeneca Covid-19 vaccine should only be given to under 65s | More ill tidings for EU as startling German announcement states AstraZeneca Covid-19 vaccine should only be given to under 65s |
| (7 months later) | |
| Germany's expert vaccine commission has said that the AstraZeneca Covid-19 jab should only be given to people between the ages of 18 and 64, in a startling statement that further dents the EU’s flailing vaccine rollout. | Germany's expert vaccine commission has said that the AstraZeneca Covid-19 jab should only be given to people between the ages of 18 and 64, in a startling statement that further dents the EU’s flailing vaccine rollout. |
| "There are currently insufficient data available to assess the vaccine efficacy from 65 years of age," the Standing Vaccine Commission said in the resolution made available by the German health ministry on Thursday. | "There are currently insufficient data available to assess the vaccine efficacy from 65 years of age," the Standing Vaccine Commission said in the resolution made available by the German health ministry on Thursday. |
| The European Medicines Agency is expected to make its own decision regarding the approval of the AstraZeneca vaccine on Friday. | The European Medicines Agency is expected to make its own decision regarding the approval of the AstraZeneca vaccine on Friday. |
| AstraZeneca CEO Pascal Soirot previously acknowledged that restrictions in terms of demographics suitable for his company's vaccine were a possibility. | AstraZeneca CEO Pascal Soirot previously acknowledged that restrictions in terms of demographics suitable for his company's vaccine were a possibility. |
| "It's possible that some countries, out of caution, will use our vaccine for the younger group. But honestly, it is fine,” Soirot said in a recent interview, adding that given the challenges in rolling out vaccines to as many people as possible, such measures might make sense. | "It's possible that some countries, out of caution, will use our vaccine for the younger group. But honestly, it is fine,” Soirot said in a recent interview, adding that given the challenges in rolling out vaccines to as many people as possible, such measures might make sense. |
| “There's not enough vaccines for everybody. So if they want to use another vaccine for older people and our vaccine for younger people, what’s the problem?” | “There's not enough vaccines for everybody. So if they want to use another vaccine for older people and our vaccine for younger people, what’s the problem?” |
| The statement comes as the EU and the British-Swedish pharmaceutical firm are embroiled in an increasingly bitter dispute about supplies. The bloc is pushing the company to deliver more doses of its vaccine after AstraZeneca announced delivery delays. | The statement comes as the EU and the British-Swedish pharmaceutical firm are embroiled in an increasingly bitter dispute about supplies. The bloc is pushing the company to deliver more doses of its vaccine after AstraZeneca announced delivery delays. |
| Meanwhile, the Pfizer/BioNTech and Moderna vaccines which have both been approved by EU regulators were considered “equivalent in terms of safety and efficacy.” | Meanwhile, the Pfizer/BioNTech and Moderna vaccines which have both been approved by EU regulators were considered “equivalent in terms of safety and efficacy.” |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |